Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study
Amita Ketkar, Vincent Willey, Michael Pollack, Lisa Glasser, Casey Dobie, Cachet Wenziger, Chia Chen Teng, Christine Dube, Dennis Cunningham, Monica Verduzco-Gutierrez
Dive into the research topics of 'Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study'. Together they form a unique fingerprint.